[How can we improve the system to analyze HCV replication system?].
Shimotohno
Kunitada
K
Institute for Virus Research, Kyoto University, Shogo-in, Sakyo-ku, Kyoto 606-8507.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D004279:DNA, Viral; D004359:Drug Therapy, Combination; D015316:Genetic Therapy; D016679:Genome, Viral; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology; D006526:Hepatitis C / Q000628:therapy* / Q000821:virology*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D012367:RNA, Viral; D012093:Replicon / Q000235:genetics; D012254:Ribavirin / Q000627:therapeutic use; D014779:Virus Replication
D000998:Antiviral Agents; D004279:DNA, Viral; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons